Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Bisoprolol Fumarate (TA-4708) in Chronic Heart Failure
jRCT2080221012Phase 3
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of bisoprolol in chronic heart failure (CHF), sponsored by Mitsubishi Tanabe Pharma Corporation.
02
Drugs
bisoprolol
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on jRCT2080221012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221012.